Dr. sc. nat. Annick Töpken


German and European
Patent Attorney



German, English, French


Dr. sc. nat. Annick Töpken
Phone +49 89 210232-0
Fax +49 89 210232-65


Dr. Annick Töpken holds a doctorate in biology and has been working in intellectual property law since 2001. She joined the team of Wallinger Ricker Schlotter Tostmann in 2021. 

Legal Activity

Dr. Töpken was admitted to practice as a German Patent Attorney in 2005 and as a European Patent Attorney in 2008. Dr. Töpken's areas of practice include the prosecution of European and international patent applications and the enforcement and defense of intellectual property rights in opposition and appeal proceedings. She also has extensive experience in drafting patent applications and coordinating international application proceedings and patent portfolios. Due to her experience in an industrial patent department, she is also familiar with the corporate view of industrial property rights.

Technical Background

Dr. Töpken studied biology at the Biozentrum of the University of Basel. Her main fields of study were biochemistry, biophysical chemistry, genetics and cell biology. She then completed her PhD in molecular neuroscience at the Institute of Cell Biology at ETH Zurich. 

Dr. Töpken's technical expertise mainly includes biotechnology, drugs (small molecules, proteins, miRNA) and their medical applications, plants, formulations, antibodies, vaccines, gene therapy, stem cells, expression systems and diagnostic methods.


Since 2021
Patent Attorney at the law firm Wallinger Ricker Schlotter Tostmann

Patent Attorney in the law firm Weickmann & Weickmann, Munich

Freelance work as Patent Attorney

Trained as a Patent Attorney at the law firm df-mp, at the Munich Higher Regional Court, at the German Patent and Trademark Office and at the Federal Patent Court

Patent Clerk, Switch Biotech AG, Martinsried, Germany

Doctorate at the ETH Zurich

Study of biology at the Biozentrum of the University of Basel


  • Patent Attorneys Association (PAK)
  • Institute of Professional Representatives before the European Patent Office (epi)
  • International Federation of Intellectual Property Attorneys (FICPI)


  • Schaeren-Wiemers N, Bonnet A, Erb M, Erne B, Bartsch U, Kern F, Mantei N, Sherman D, Suter U., The raft-associated protein MAL is required for maintenance of proper axon-glia interactions in the central nervous system, J. Cell. Biol. 30, 166: 731-42, 2004.
  • Caduff J, Sansano S, Bonnet A, Suter U, Schaeren-Wiemers N., Characterization of GFP-MAL expression and incorporation in rafts, Microsc. Res. Tech. 15, 52: 645-55, 2001
  • Roth LW, Bormann P, Bonnet A, Reinhard E., beta-thymosin is required for axonal tract formation in developing zebrafish brain, Development, 126: 1365-74, 1999.